MedTrace Logo

POLARSTEM Retrospective Multicenter Study

NCT02680340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502

Last updated 2017-02-23

No results posted yet for this study

Summary

The primary purpose of this study is to demonstrate the POLARSTEM™ Ti/HA cumulative femoral stem revision rate at 10 years.

The secondary purpose of this study is to provide 10 years of safety and effectiveness data of POLARSTEM™ Ti/HA in terms of radiographic and clinical performance

Conditions

Interventions

PROCEDURE

Total Hip Arthroplasty

Patients who had a primary THA between 2002 and 2005

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    lead INDUSTRY

Principal Investigators

  • Arnaud Fiquet, Dr. med. · Infirmerie Protestante de Lyon

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-10-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02680340 on ClinicalTrials.gov